A detailed history of Act Capital Management, LLC transactions in Surface Oncology, Inc. stock. As of the latest transaction made, Act Capital Management, LLC holds 170,500 shares of SURF stock, worth $0. This represents 0.24% of its overall portfolio holdings.

Number of Shares
170,500
Previous 170,500 -0.0%
Holding current value
$0
Previous $280,000 36.79%
% of portfolio
0.24%
Previous 0.39%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021

BUY
$6.45 - $9.09 $1.1 Million - $1.55 Million
170,500 New
170,500 $1.27 Million

Others Institutions Holding SURF

# of Institutions
2
Shares Held
315K
Call Options Held
0
Put Options Held
0

About Surface Oncology, Inc.


  • Ticker SURF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,034,000
  • Description
  • Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibo...
More about SURF
Track This Portfolio

Track Act Capital Management, LLC Portfolio

Follow Act Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Act Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Act Capital Management, LLC with notifications on news.